CRSP - CRISPRセラピュ―ティクス (CRISPR Therapeutics AG) CRISPRセラピュ―ティクス

 CRSPのチャート


 CRSPの企業情報

symbol CRSP
会社名 CRISPR Therapeutics AG (CRISPRセラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA) which is comprised of a crRNA component and a tracrRNA component either individually or combined together as a single guide RNA. The Company has business operations in London the United Kingdom as well as research and development operations in Cambridge the United States.   CRISPRセラピュ―ティクスはスイスのバイオ医薬品企業。ゲノム編集に従事し、遺伝子ベ―スの病気の治療に使用される「CRISPR/Cas9」プラットフォ―ムを開発する。スイス、米国、英国で事業を展開する。「CRISPR」ベ―スの開発をバイエルとバ―テックス・ファ―マシュ―ティカルズと協業する。本社はバ―ゼル。   CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.
本社所在地 Baarerstrasse 14 Zug 6300 CHE
代表者氏名 Rodger Novak ロジャーノヴァク
代表者役職名 Chairman of the Board of Directors President Founder
電話番号 +41 41-561-3277
設立年月日 41548
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 127人
url www.crisprtx.com
nasdaq_url https://www.nasdaq.com/symbol/crsp
adr_tso
EBITDA EBITDA(百万ドル) -83.54900
終値(lastsale) 36.6
時価総額(marketcap) 1732197333.6
時価総額 時価総額(百万ドル) 1894.215
売上高 売上高(百万ドル) 37.15800
企業価値(EV) 企業価値(EV)(百万ドル) 1574.478
当期純利益 当期純利益(百万ドル) -84.94600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Crispr Therapeutics AG revenues decreased 61% to $2.4M. Net loss increased 52% to $66.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development - Balancing increase of 31% to $37.1M (expense) Stock-based Compensation in R&D increase from $3.7M to $8.1M (expense).

 CRSPのテクニカル分析


 CRSPのニュース

   Nobel Prize for Gene-Editing Innovators Boosts Crispr Therapeutics and Other Stocks  2020/10/07 14:04:00 Barron's
This year’s Nobel Prize for chemistry was awarded Wednesday to the two discoverers of Crispr/Cas9, which has led to gene-editing treatments for inherited illnesses like sickle-cell anemia.
   Crispr Therapeutics Gets an Upgrade but Needs Help on the Charts  2020/10/05 18:23:32 The Street RealMoney
Crispr Therapeutics Gets an Upgrade but Needs Help on the Charts…CRSP
   Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More – 24/7 Wall St.  2020/10/05 13:09:07 24/7 Wall street
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
   CRISPR Therapeutics Stock Is a Strong Buy on the Dip  2020/09/09 15:36:01 InvestorPlace
CRSP stock has pulled back 13% in the last two sessions on no news. The dip allows investors into a strong long-term story at a lower price.
   CRISPR Therapeutics Stock Shows It Has Good Genes  2020/08/18 15:41:07 The Street RealMoney
CRISPR Therapeutics Stock Shows It Has Good Genes in Its Charts…CRSP
   CRISPR Therapeutics Stock Is a Strong Buy on the Dip  2020/09/09 15:36:01 InvestorPlace
CRSP stock has pulled back 13% in the last two sessions on no news. The dip allows investors into a strong long-term story at a lower price.
   CRISPR Therapeutics Stock Shows It Has Good Genes  2020/08/18 15:41:07 The Street RealMoney
CRISPR Therapeutics Stock Shows It Has Good Genes in Its Charts…CRSP
   CRISPR Therapeutics: My #1 High-Risk Investment Idea (NASDAQ:CRSP)  2020/08/14 18:55:02 Seeking Alpha
CRISPR Therapeutics sits at the forefront of the CRISPR/CAS9 gene-editing breakthrough. CTX001 data for Sickle Cell Disease & Beta-Thalassemia is extremely promising.
   Frontier Perspectives: CRISPR Therapeutics  2020/08/07 03:30:04 Medium
Since its initial discovery as a genetic reprogramming tool in 2012, CRISPR has widely been regarded as a breakthrough scientific discovery and quickly become one of the hottest new biotechnologies…
   Bullish Signal Could Mean New Heights for Gene Therapy Stock  2020/08/05 18:52:02 Schaeffers Investment Research
Crispr Therapeutics stock is flashing a bull signal that could send it to previously unseen heights
   CRISPR Therapeutics Stock Shows It Has Good Genes  2020/08/18 15:41:07 The Street RealMoney
CRISPR Therapeutics Stock Shows It Has Good Genes in Its Charts…CRSP
   CRISPR Therapeutics: My #1 High-Risk Investment Idea (NASDAQ:CRSP)  2020/08/14 18:55:02 Seeking Alpha
CRISPR Therapeutics sits at the forefront of the CRISPR/CAS9 gene-editing breakthrough. CTX001 data for Sickle Cell Disease & Beta-Thalassemia is extremely promising.
   Frontier Perspectives: CRISPR Therapeutics  2020/08/07 03:30:04 Medium
Since its initial discovery as a genetic reprogramming tool in 2012, CRISPR has widely been regarded as a breakthrough scientific discovery and quickly become one of the hottest new biotechnologies…
   Bullish Signal Could Mean New Heights for Gene Therapy Stock  2020/08/05 18:52:02 Schaeffers Investment Research
Crispr Therapeutics stock is flashing a bull signal that could send it to previously unseen heights
   Global CRISPR Technology Market Outlook 2020-2030 - Industry Driven by CRISPR Technology Being Used as a Diagnostic Tool for COVID-19 - ResearchAndMarkets.com  2020/08/03 09:49:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "CRISPR Technology Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Where is the largest and fastest growing market for the crispr technology market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This global market report answers all these questions and many more. The global CRISPR technology market is expec

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 CRISPRセラピュ―ティクス CRSP CRISPR Therapeutics AG)

 twitter  (公式ツイッターやCEOツイッターなど)